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      Studies on the Metabolism of Fission Products 
    II. Studies on the Metabolism of the Radioisotopes 
       Contained in the Radioactive Ashes Obtained 
            from the No. 5  Fukuryu Maru
,Takehiko KIKUCHI, Gyoichi WAKISAKA, Tsuyoshi KoNo, Hiroshi GOTO, 
          Hiroaki AKAGI, Tsunehisa YAMAMASU, and Isamu SUGAWA 
          (The Second Medical Clinic, Faculty of Medicine,Kyoto University) 
INTRODUCTION 
   The metabolism of the fission products contained in the radioactive ashes obtain-
ed from the No. 5 Fukuryu Maru has been studied in adult mice. The radioelements 
studied were yttrium, cerium, praseodymium, calcium, strontium, ruthenium, rhodium, 
zirconium, niobium, and iodine. 
                  MATERIALS ANI) METHODS 
   As experimental animals adult mice ranging in body weight from 10 to 16 grams 
were used. Usually 4 to 5 mice were used in each experiment. However, when the 
material was very small in amount, 2 to 3 mice were employed in one experiment. 
For the study of the metabolism of IL31, adult rats weighing about 150 grams were 
also used. The radioisotopes, Y°1, Ce 1`11, '`', Pr141, Ru103,10J , Rh'°, Zr°5 and Nb05 
were separated from the radioactive ashes using ion exchange resin Amberlite IR-
120. The method of separation has been reported in detail'). The radioisotopes 
were diluted with physiologic saline solution so as to make the radioactivity 15,000 
to 50,000 counts per miniute per cc., and the pH of the solution was adjusted to 
6.0. Ru1°3,1" and Rh1°0 were obtained as hydrochloric acid solution by the ion 
exchange resin method, while Zr °J and Nb°5 were obtained as the oxalate. In order to 
destroy the oxalate, the fraction containing Zr" and Nb95 was treated with nitric acid, 
heated to dryness and dissolved in physiologic saline solution. For the separation of 
Y°1 and Ce'" '11`' Prl'' ', 2mg. of inert rare earths were added as carrier to the radio-
active ashes, and after the removal of silicon with hydrogen fluoride and perchloric 
acid, the ion exchange resin method was applied. As the fraction thus obtained con-
tained citrate, the solution was wet ashed with perchloric acid and hydrogen peroxide 
in order to destroy the citrate, and Y°1 and Ce'41'1" Pr"' were precipitated from neutral 
medium. The precipitate was dissolved in hydrochloric acid, diluted with physiologic 
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 saline solution, and the pH was adjusted to 6.0. For the study of the metabolism of 
 radiostrontium, radiocalcium and radioiodine, the radioisotopes supplied by the U. S. 
 AEC were used. The radioisotopes were given by mouth or subcutaneously to adult 
 mice. For oral administration, a stomach tube, 1 mm. in diameter, attached to a 
 syringe was used in order to introduce the material directly into the stomach. In 
 case of subcutaneous injection, the material was injected between the two shoulder 
 blades in the back of the animals. For the disinfection of the injection site tincture 
 of iodine was used in order to prevent the animals from licking the injection site. 
 The animals were sacrificed 12 hours following the oral administration or 4 and 12 
 hours following the subcutaneous injection, (in case of  Srso,10 12 and 24 hours and 
 4, 14 and 30 days following the injection) and the liver, lungs, kidneys, spleen, 
 blood, digestive tract (including the stomach, small and large intestines together 
 with their contents) and bones (both femurs, tibias and fibulas including the bone 
 marrow) were removed, weighed, and wet ashed with perchloric acid and hydrogen 
 peroxide. The samples were transferred into glass dishes, 3 cm. in diameter, dried, 
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     Fig. 1. Elution curve of cation exchange group separation for animal experiments, 
            using Amberlite IR-120 (60 mesh, 1 cm. q x 70 cm.). 
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and the radioactivity was measured with a Geiger-Mueller counter and a "100" 
scaler. As a standard, the same amount of the material as the administered dose 
(or 1/100 of the administered dose) was treated in the same way as the samples 
and the radioactivity was measured under the same conditions. For the measure-
ment of radioiodine a scintillation counter was used. 
    The results were expressed as per cent of the administered dose per gram tissue 
and per whole organ. 
    In case of Ru103"0° Rh10' the tissues were spread uniformly between two sheets 
of thin paper and dried at 37'C. in an incubator to prevent ruthenium and rhodium 




  50 
                                                                                           Half-thlcknea   20 • I210 mg/cm4                              
I 1                                                                • 10 t. 
°a 1 o 
                                                •5Half-thicness 510 mg/cm' <Half-thickpess 
76 mg/cm2 
2 2 
    1 1 
0200400600 mg/cm2 p5001000 mg/cm2 
                        Fig. 4. Al absorption curve for Ca". 





                       5Half-tbickneae                                                        5.2 mg/ca2 
2 
1 
            01020 mg/~2 30. 
( 86 )
                  Studies on the Metabolism of Fission Products  II. 
from being lost by evaporation during wet ashing with perchloric acid. For the 
radioactivity measurement of the radioisotopes with low energy beta particles, such 
as Ca45, Ru703,106 Rh106 and Zr35 Nb95, self absorption correction was made by 
measuring the weight of the samples. 
   As the radiostrontium used in our experiments was a mixture of Sr" and SrJ0, 
YJ0 was contained as a daughter product of Sr". Although Y30 might have exerted 
some influence upon the metabolism of radiostrontium, radioactivity measurement 
was made only once 24 hours after the preparation of the samples, and no further 
analysis was made. Fig. 1 shows the elution curve obtained by the ion exchange 
resin method, and Figs. 2 —8 show the aluminium absorption curves') of the radio-




u 20 zo , -----& 
Half-thickness 
           160 mg/cm2 10 
  10 
Half-thickness 
<< 5320 mg/cm2 
5 Ha 1-thickness 
18 mg/cm2 
 I~ 2 





0500 1000 .8/m2 1500 
 0250500 750 
                                           .g/cm2 
                     Fig. 7. Al absorption curve for Zr95 and Nb95. 
100 
                      50 1
` 
20 \(\ 10\ 
2 0100200300 mg/cm2 
(87)
                          T.  KIKUCHI, G. WAKISAKA et al. 
isotopes used in our experiments. 
                          Fig. 8. Al absorption curve for Ii31. 
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   (1) Y91 (Table 1 and Figs. 9, 10, 11) 
   The absorption of YJI from the digestive tract following the oral administration 
was poor. When administered subcutaneously, Y91 was deposited chiefly in the 
bones. Four hours following the subcutaneous injection, the radioactivity per gram 
tissue of the bones was the highest, followed by that of the digestive tract, kidneys 
and liver in this order. The excretion of YJ1 occurred through the kidneys and 
digestive tract. 
Fig. 9. Distribution of YJ1 in the tissues of Fig. 10. Distribution of Y91 in the tissues of 
       the mouse 12 hours following oral the mouse 4 hours following subcutaneous 
       administration (per gram).injection (per gram). 
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            Table 1. Distribution of Y71 and Ce1u,i1_t Pr111 in the tissues of the mouse 
      ElementYJ1Y91 Ce/4114t Pr1.0 
    Method ofOralSubcutan.Subcutan. 
     administrationadmin.injectioninjection 
     Time after12 hrs.4 hrs. 12 hrs.4 hrs.         administration 
   Number of animals55 32 
     Liver p. w. o. 0.19±0.070,37 ±0.090.49± 0.09 0.08±0.02 
                 p. g. t. 0.21±0.06 0.67±0.39 0.75±0.14 0.13±0.02 
     Spleen p. w. o. 0.04±0.01 0.00±0.00 0.01±0.01 0.01±0.005 
                 p. g. t. 0.62±0.18 0.00±0.00 0.20±0.19 0.13±0.12 
     Lung p. w. o. 0.04±0.02 0.01±0.01 0.05±0.03 0.01±0.01 
                 p. g. t. 0.24±0.12 0.07±0.04 0.37±0.23 0.11±0.11 
      Digest. tract p. w. o. 53.87±11.84 2.52±1.83 2.88±1.02 0.25±0.14 
                 p. g. t. 18.70±3.73 1.31±0.90 1.26±0.50 0.11±0.04 
     BloodP. g. 0.05±0.01 0.18±0.14 0.04±0.01 0.12±0.025 
     Kidneyp. w. o. 0.06±0.03 0.16±0.09 0.06±0.03 0.02±0.015 
                 p. g. t. 0.27±0.11 1.15±0.73 0.43±0.19 0.075±0.075 
     Bonep. W. S. 0.02±0.01 2.98±1.26 0.47±0.12 0.11±0.015 
                 p. g. t. 0.15±0.07 10.78±4.70 2.01±0.59 0.42±0.035 
             p. w. o. per whole organ 
             p. g. t. per gram tissue 
p. g. per gram 
              p. w. S. per whole sample (both femurs, tibias and fibulas) 
          Values are presented as group means of the percent of the administered dose 
          ± the standard error of the mean. 
   Fig. 11. Distribution of Y,1 in the tissues of Fig. 12. Distribution of Ce111,114 and Pr1.11 
           the mouse 12 hours following sub-in the tissues of the mouse 4 hours follow-
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   (2) Ce'" ,14, Pr'4' (Table 1 and Fig. 12) 
   Four hours following the subcutaneous injection of Ce'41>14 and PrL 4 the radio-
activity per gram tissue was highest in the bones. However, the deposition of 
Ce'`">'`'.' and Pr'4' in the bones was much less as compared with that of Y°'. Small 
amounts of radioactivity were also found in the liver, spleen, digestive tract and 
kidneys. 
   (3) Ca'5 (Table 2 and Figs. 13, 14) 
   The absorption of Ca" from the digestive tract was moderately good, and less 
than 8 % of the administered dose remained in the gastrointestinal tract 12 hours 
following the oral administration. The main deposition site of Ca" was the bones 
following both the oral and subcutaneous administrations. The excretion of Ca4' 
occurred through the kidneys and the digestive tract. 
             Table 2. Distribution of Ca45 in the tissues of the mouse 
    ElementCa45  Cat" 
       Method of administrationOral admin. Subcutan. injection 
     Time after administration12 hrs.4 hrs.
  Number of animals45 
    Liverp. w. O.0.73±0.271.37±0.26 
              p. g. t.1.18±0.261.99±0.44 
    Sleenp. w. O.0.11±0.020.21±0.05 
              p .g. t.0.85±0.053.46±0.81 
    Lungp. w. O.0.25±0.160.07±0.005 
              p. g. t.1.44±0.840.36±0.03 
     Digest. tract p. w. o.6.81±0.196.99±0.68 
              p. g. t.3.76±0.902.96±0.28 
    BloodP. g.2.43±0.334.15±0.94 
    Kidneyp. w. O.0.08±0.041.36±0.42 
              p. g. t.0.43±0.236.13±2.04 
    Bonep. w. S.6.29+0.637.71±1.19 
              p. g. t.24.90±3.529.25±4.96 
         p. w. o. per whole organ 
         p. g. t. per gram tissue 
P. g. per gram 
          p. w. S. per whole sample (both femurs, tibias and fibulas) 
   Values are presented as group means of the percent of the administered dose 
   ± the standard error of the mean. 
   (4) Sew0 (Table 3 and Figs. 15, 16, 17, 18, 19) 
                           ( 90
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   Fig. 13. Distribution of Caul in the tissues Fig. 14. Distribution of Ca the tissues 
          of the mouse 12 hours followingof the mouse 4 hours following 
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      Twelve hours following the oral administration, Sr"," was deposited chiefly in 
   the bones. The absorption of Sr"," from the digestive tract was much better than that 
   of Y31 and Ce11 "44, Pl'4'. Four hours following the subcutaneous injection, the deposi-
                 Table 3. Distribution of Sr49'°0 in the tissues of the mouse
Method of admi-Subcutan.Subcutan.Subcutan.Subcutan.Subcutan.Subcutan. 
nistrationOral admin.injection injection injection injection injection injection 
Time after admi- 12 hrs.4 hrs.12 hrs.24 hrs.4 days 14 days 30 days nistration _ 
Number of5 55555 5 
animals  
Liver p.w. o. 0.06±0.01 0.83± 0.11 0.80± 0. 06 0.67± 0. 09 0.29± 0. 02 0.04± 0. 00710. 013±0. 004 
        p. g. t. 0.08+0.02 1.38±0.13 1.28±0.10 1.43±0.14 0.57±0.04 0.06±0.0130.018±0.002 
Spleen p.w. o. 0.007+0.003 0.02± 0. 003 0.02± 0. 007 0.01± 0. 00 0.01±0. 002 0.00±0. 00 0.00± 0.00 
        p. g. t. 0.14±0. 07 0.35±0. 05 0.28± 0. 07 0.20± 0. 02 0.13±0.023 0.00±0.00 0.00±0.00 
Lungp.w. o. 0.02± 0. 009 0.12±0. 02 0.08± 0. 006 0.04± 0. 01 0.02± 0. 006 0.002± 0. 0020. 001±0. 001 
        p. g. t. 0.16±0.05 1.12±0.24 0.73±0.05 0.27±0.04 0.18±0.031 0.02±0.0060.004±0.002 
Digest. p.w.o. 10.51±5.05 2.93±0.39 3.57±0.55 1.54±0.12 0.37±0.10 ( 0.08±0.0120.027±0.017 
tract P• g.t. 4.15±2.06 1.05±0.18 1.73±0.06 0.85±0.17 0.18±0.04 0.05±0.007 0.01±0.007 
Blood p. g. 0.14±0.03 0.90±0.29 10.59±0.12 0.38±0.09 0.08±0.03 0.02±0.0050.001±0.0002 
Kidney p.w. o. 0.02-±0.007 0.32±0.026 0.31±0.02 0.20±0.04 0.11±0.0060.008±0.0020.001±0.0001 
        p. g. t. 0.16±0.06 0.72±0.05 2.51±0.28 1.40±0.41 0.97±0.037 0.02±0.0090.005±0.002 
Bone p.w. s. 1.05±0.20 2.67±0.32 3.69±0.46 3.12±0.44 2.69±0.15 1.81±0.27 1.24±0.17 
        p. g. t. 5.90±0.96 19.64±4.12 18.14±2.50 18.39±1.13 14.24±0.79 10.33±0.67 7.52±0.84 
p. w. o. per whole organ 
p. g. t. per gram tissue 
• g• per gram 
p. w. s. per whole sample (both femurs, tibias and fibulas) 
          Values are presented as group means of the percent of the administered dose 
             the standard error of the mean. 
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Fig. 15. Distribution of Sr49.90 in the tissues Fig. 16. Distribution of SrS',90 in the tissues 
       of the mouse 12 hours followingof the mouse 4 hours following 
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           Fig. 17. Distribution of Sr89 9° in the tissues of the mouse 12 hours 
                   following subcutaneous injection (per gram). 
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      Fig. 18. Distribution of SrSS,90 in the tissues of the mouse 4, 12 and 24 hours 
              and 4, 14 and 30 days following subcutaneous injection (per gram). 
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tion of  Srs9,9° was also highest in the bones. The excretion of Srs9,so occurred 
through the kidneys and digestive tract. The radiostrontium, deposited in the tissues 
other than the bones, was eliminated relatively rapidly, while the elimination of the 
radiostrontium deposited in the bones was very slow, and even 30 days following 
the subcutaneous injection a considerable amount of the radiostrontium was still 
remaining in the bones. 
      Fig. 19. Distribution of Sr99,9° in the tissues of the mouse 4, 12 and 24 hours 
             and 4, 14 and 30 days following subcutaneous injection (per gram). 
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   (5) Ru103'100Rh10°(Table 4 and Figs. 20, 21) 
   The absorption of Rulo>,100 and Rh100 from the digestive tract was poor. The 
deposition of Ru103>'01 and Rh100 in the bones was also poor. Ru'as,19° and Rh'p0 
showed a tendency to be deposited in the kidneys, liver, lungs and spleen. 
   (6) Zr", Nb95 (Table 4 and Figs. 22, 23) 
   The absorption of Zr95 and Nb95from the digestive tract was not good. Four 
hours following the subcutaneous injection 11.519 of the administered  dose was ex-
creted mainly through the kidneys, and partly through the digestive tract, and only 
a small amount of the administered dose was deposited in the bones. Zr95 and Nb95 
showed a tendency to be deposited in the spleen and lungs. Zr" and Nb95 tended 
to form colloidal aggregates, and the uptake of these radioisotopes by the spleen 
and lungs might be partly explained by the phagocytosis of the elements by the 
reticuloendothelial cells in these organs. When silicon is present with Zr" and Nb95, 
this tendency would be enhanced, because the colloid aggregates of Zr95 and Nb95 
are absorbed on the silicon. 
   (7) I131 (Table 5 and Figs. 24, 25) 
   The absorption of I1s' from the digestive tract was excellent. When injected sub-
cutaneously, the excretion occurred through the kidneys and partly through the 
                          ( 93 )
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    Table 4. Distribution of Rul°s,L°a Rh10' and Zr'5, Nb''il in the tissues of the mouse 
      ElementRuL03,WO, Rh /06 Zrca, Nb'a Zr0, Nb05 
Method ofSubcutan.Subcutan. 
administrationOral admin.injectionOraladmin.injection 
    Time after12 hrs. 4 hrs. 12 hrs.4 hrs.        administration 
 Number of animals22 22 
  Liverp. w. O. 0.16 0.22±0.06 0.02+0.00 0.08±0.01 
            p. g. t. 0.25 0.49±0.11 0.03_k0.00 0.11±0.04 
  Spleenp. w. O. 0.05 0.04±0.04 0.00±.000 0.05±0.01 
            p. g. t. 0.53 0.27±0.27 0.00±0.00 0.59±0.02 
  Lungp. w. O. 0.11 0.06±0.02 0.03±0.01 0.03±0.01 
           p. g. t. 0.72 0.34±0.06 0.25±0.03 0.19±0.09 
  Digest. tract p. w. o. 28.83 0.58±0.14 36.49±4.81 0.17±0.04 
            p. g. t. 8.24 0.28±0.12 19.70±2.50 0.09±0.0? 
  BloodP. g. 0.36 0.37±0.24 0.05±0.02 0.13±0.00 
  Kidneyp. W. O. 0.11 0.13±0.08 0.02±0.01 0.04±0.00 
           p. g. t. 0.56 0.52±0.29 0.15±0.10 0.27±0.00 
  Bonep. w. S. 0.28 0.24±0.15 0.04±0.02 0.20±0.04 
           p. g. t. 0.62 0.78±0.51 0.25±0.05 1.00±0.20 
 Excretatotal 48.36 2.70±0.1511.51 
p. w. O. per whole organ 
         p. g. t. per gram tissue 
P. g. per gram 
          p. W. S. per whole sample (both femurs, tibias and fibulas) 
      Values are presented as group means of the percent of the administered dose 
       ± the standard error of the mean. 
Fig. 20. Distribution of Rul°;,i°° and Rh10" in Fig. 21. Distribution of Ru'°0' 0' and Rh o" in 
       the tissues of the mouse 12 hoursthe tissues of the mouse 4 hours 
       following oral administration (perfollowing subcutaneous injection 
grarn).(per gram). 
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Fig. 22. Distribution of  ZrJ5 and Nb`i5 in the Fig. 23. Distribution of Zr55 and Nb95 in 
       tissues of the mouse 12 hoursthe tissues of the mouse 4 
        following oral administration (perhours following subcutaneous 
gram),injection (per gram). 
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             Table 5. Distribution of I131 in the tissues of the mouse and rat 
     Element11311131 
       Method of administrationOral admin.Subcutan. injection 
     Time after administration12 hrs.4 hrs. 
      Number of animals2 mice3 rats 
    Liverp. w. o.0.29±0.022.81±1.87 
              p. g. t.0.30+0.030.46±0.29 
     Spleenp. w. o.0.02±0.000.18±0.05 
              p. g. t.0.48±0.020.36±0.08 
    Lungp. w. o.0.08±0.011.86±1.06 
              p. g. t.0.50±0.011.77±0.88 
      Digest. tract p. w. o.2.47±0.7136.45±0.63 
              p. g. t.1.10±0.422.98±0.04 
    BloodP. g.1.37±0.561.02±0.34 
     Kidneyp. w. o.0.20±0.030.96±0.32 
              p. g. t.1.52±0.380.71±0.25 
    Bonep. W. s.0.17±0.011.78±0.04 
              p. g. t.1.06±0.130.60±0.02 
   Thyroid p. g. t.380 
          p. w. O. per whole organ 
          p. g. t. per gram tissue 
P. g. per gram 
           p. w. s. per whole sample (both femurs, tibias and fibulas) 
        Values are presented as group means of the percent of the administered dose 
        ± the standard error of the mean. 
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digestive tract. Four hours following the subcutaneous injection of I111 in adult 
rats the deposition of I131 in the thyroid amounted to 380 % of the administered dose 
per gram tissue. 
Fig. 24. Distribution of I01 in the tissues of Fig. 25. Distribution of PI in the tissues 
       the mouse 12 hours following oralof the rat 4 hours following 
       administration (per gram).subcutaneous injection (per gram). 
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                       DISCUSSION 
   The metabolism of fission products has been studied by many investigators30''077) 
using the radioisotopes produced in the cyclotron or uranium pile reactor. In our 
experiments most of the fission products studied were separated from the radioactive 
ashes collected from the No. 5 Fukuryu Maru. For the separation of rare earths 
inert elements were added as carrier. However, the amount of the carrier added 
was so small that the influence of the carrier upon the metabolism of the radio-
elements would have been negligible. For the separation of the radioisotopes other 
than the rare earths no carrier was added. As the material used in our experiments 
was originally separated from the dust collected from the deck of the No. 5 Fuku-
ryu Maru, there was a possibility that the material contained many impurities such 
as iron, copper, zinc, calcium, silicon, chromium, etc. Although these impurities 
were removed as much as possible, some of them might have remained in the 
test dose and exerted some influence upon the metabolism of the fission products. 
Be that as it may, the results obtained in our experiments were similar to those 
reported by other investigators. Among the radioisotopes studied, radioiodine, radio-
calcium and radiostrontium were readily absorbed from the digestive tract, while 
the absorption of the rare earths from the digestive tract was poor. The radio-
element s which accumulated chiefly in the bones were radiocalcium, radiostrontium 
and radioyttrium. Radiostrontium rapidly concentrates in the skeleton, and it is 
very slowly excreted, with a biological half-life of 3.9 x10' days.") Therefore, 
( 9fj )
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among the fission products studied, radiostrontium appears to be the most import-
ant radioisotope, which accumulates in the skeleton and causes biological hazards. 
The heavy metals such as radioruthenium and radiorhodium tended to be distributed 
in the kidneys, liver, lungs and spleen. 
                        SUMMARY 
   1) The metabolism of the radioisotopes found in the radioactive ashes collected 
from the No. 5 Fukuryu Maru has been studied in adult mice. The radioisotopes 
studied were Y"1, Ce'`""'`'`', Pr144, Ca45, Sr99,90, Ru10121°0 Rh706 Zr95, Nb95 and I"1 
   2) Among the radioisotopes studied, radiostrontium, radiocalcium and radio-
yttrium accumulated chiefly in the bones, and the elimination of radiostrontium from 
the bones was very slow. 
   3) When administered by mouth, radiostrontium and radiocalcium were readily 
absorbed from the digestive tract, while the absorption of radioyttrium from the 
digestive tract was poor. 
   4) Among the radioisotopes studied, radiostrontium appears to be the most im-
portant radioisotope as a cause of biological hazards, when the radioactive ashes are 
taken by mouth. 
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